Skip to main content
Premium Trial:

Request an Annual Quote

Beckman Coulter Stock Climbs 8 Percent on Positive Q3 Results, Deal Announcement

NEW YORK, Nov. 2 (GenomeWeb News) - Shares in Beckman Coulter were up 8 percent, or $3.94, at $53.44 in mid-afternoon trading after the company announced its third-quarter results and a multi-million-dollar deal this morning.


As GenomeWeb News reported earlier today, Beckman Coulter had a 2-percent increase in third-quarter revenues of $593.4 million and that international sales grew by 3.8 percent. However, net income fell to $36.2 million from $57.2 million year over year.


Separately today, Beckman signed a multi-million dollar deal with Consorta to provide the suburban Chicago based company its chemistry, immunodiagnostics, and automation product lines.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.